Globe Newswire
- 150+ Partners Across Every Layer of AI Ecosystem Embedding NIM Inference Microservices to Speed Enterprise AI Application Deployments From Weeks to Minutes
- NVIDIA Developer Program Members Gain Free Access to NIM for Research, Development and Testing
TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- COMPUTEX -- NVIDIA today announced that the world’s 28 million developers can now download NVIDIA NIM™ — inference microservices that provide models as... (continue reading...)
TAIPEI, Taiwan, June 02, 2024 (GLOBE NEWSWIRE) -- COMPUTEX -- NVIDIA today announced the general availability of NVIDIA ACE generative AI microservices to accelerate the next wave of digital humans, as well as new generative AI breakthroughs coming soon to the platform.
Companies in customer service, gaming and healthcare are the first to adopt ACE technologies to simplify creating, animating and operating lifelike digital humans across customer service,... (continue reading...)
- Extended follow-up data reaching over two years in the earliest patients dosed reinforce the potential of NTLA-2002 to be a functional cure for people living with hereditary angioedema (HAE)
- Eight of 10 patients remain completely attack-free following the 16-week primary observation period through the latest follow-up, including patients with the most severe disease
- Single dose of NTLA-2002 led to a 98% mean reduction in monthly HAE attack rate, with an average follow-up... (continue reading...)
Los Angeles, CA, USA , June 02, 2024 (GLOBE NEWSWIRE) --
Today, OkayCoin, a frontrunner in cryptocurrency staking solutions, marked a significant milestone with the announcement of the upcoming launch of its proprietary OkayCoin Staking Protocol. Under the visionary leadership of CEO William Miller, the new protocol is set to revolutionize the way users engage with staking, enhancing both the profitability and the security of their investments.
William Miller,... (continue reading...)
Miami, FL, June 02, 2024 (GLOBE NEWSWIRE) --
In response to the ongoing volatility in the cryptocurrency markets, CryptoHeap, a leading provider of cryptocurrency staking services, has introduced a strategic blueprint designed to optimize staking outcomes for investors during these fluctuating conditions. This innovative strategy focuses on adapting to market changes dynamically, enhancing risk management, and maximizing staking rewards.
Salvage Warwick, the... (continue reading...)
More Globe Newswire
View Older Stories-
BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with Normal C1-Inhibitor after Beginning ORLADEYO® (berotralstat) Treatment
-
ePac Flexible Packaging Sets Strategy for Continued Double-Digit Growth
-
BIOGEN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Biogen Inc. and Encourages Investors to Contact the Firm
-
Heineken® Celebrates Thousands of ‘Real Hardcore Fans’ by Helping Them Take Part in the UEFA Champions League Final Trophy Celebrations For The First Time Ever
-
National Skills Champions are Honoured at the Skills Canada National Competition 2024, in Québec
-
First Federal Savings Bank and ICBA Offer Tips to Help Simplify the Homebuying Process
-
Affimed Provides Follow-up Data of AFM24 plus Atezolizumab Showing Durable Responses in Heavily Pretreated NSCLC EGFR Wild-type Patients and Positive Initial Data from the NSCLC EGFR Mutant Cohort
-
Union members and allies mark Injured Workers’ Day in locations across Ontario
-
Prospera Energy Inc. Announces 2023 Financial Results
-
Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-sma
-
Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical
-
Flash News: OKX Announces Position Tier Adjustments for TURBO/USDT Perpetual Futures Listing
-
ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System
-
Werewolf Therapeutics to Present Data from Ongoing Phase 1/1b Clinical Trial of WTX-124 as Monotherapy and in Combination with Pembrolizumab in Solid Tumors
-
FSLY INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Fastly, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
Y-mAbs Announces Publication of Preclinical GD2-SADA Data at 2024 ASCO Annual Meeting
-
Ultimovacs Announces Poster Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Y-mAbs Announces New Interim Analysis of Phase 2 Data for Naxitamab at 2024 ASCO Annual Meeting
-
CryptoHeap Targets Top Position in Crypto Staking Industry Before Bull Run Concludes
-
Molecular Partners Presents Positive Data From Completed Phase 1 Trial Of MP0317 (FAP X CD40 DARPin) Monotherapy In Patients With Advanced Solid Tumors At ASCO 2024
-
Purple Biotech Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonstrating CM24 Improved Overall Survival and other Efficacy Endpoints in Pancreatic Cancer
-
OkayCoin CEO Releases Key Strategies to Maximize Investor Returns on Staking Platform
-
Kymera Therapeutics Presents New Clinical Data from Ongoing Phase 1 Trial of MDM2 Degrader KT-253 at ASCO Annual Meeting
-
Immunocore presents KIMMTRAK clinical data demonstrating that patients with stable disease and confirmed tumor reduction have similar clinical outcomes to patients with partial response
-
ENPH INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Enphase Energy, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
Cullinan Therapeutics Announces Positive Initial Data from Pivotal Phase 2b REZILIENT1 Study of Zipalertinib
-
VENTYX SHAREHOLDER REMINDER: BFA Law Reminds Ventyx Biosciences, Inc. (NASDAQ: VTYX) Shareholders to Contact the Firm About Ongoing Investigation
-
SQSP (NYSE) REMINDER: BFA Law Reminds Squarespace Shareholders to Inquire About Ongoing Investigation into the $44 Buyout Offer
-
SPT (NYSE) FRAUD ALERT: Sprout Social, Inc. Investors who Lost Money when Stock Plummeted 40% are Encouraged to Contact BFA Law about Upcoming Deadline
-
PATH (NYSE) INVESTOR ALERT: UiPath, Inc. Investigated for Securities Fraud After 34% Stock Drop, Contact BFA Law if You Suffered Losses
-
CERE (NASDAQ) REMINDER: BFA Law Reminds Cerevel Shareholders to Inquire About Ongoing Investigation into the $45 Merger Offer
-
CAE (NYSE) INVESTOR ALERT: CAE, Inc. Investigated for Securities Fraud from Impairment Charges, Contact BFA Law if You Suffered Losses
-
BIIB (NASDAQ) FRAUD ALERT: Biogen Inc. Investors who Lost Money are Encouraged to Contact BFA Law about Upcoming Legal Deadline
-
NIO Inc. Provides May 2024 Delivery Update
-
XPENG Announces Vehicle Delivery Results for May 2024
-
Subsea7 awarded four PLSV contracts in Brazil
-
Swiss Properties Invest has finalised the acquisition of an attractive commercial property in Koblenz in the Canton of Aargau
-
Flash News: OKX Lists WLD/USDC Spot Trading Pair
-
Li Auto Inc. May 2024 Delivery Update
-
Cielo Announces Final Closing of Private Placement of Convertible Debenture Units
-
2024 Canadian Screen Award Winners Announced
-
DIRECT DIGITAL ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Direct Digital Holdings, Inc. and Encourages Investors to Contact the Firm
-
CHECKPOINT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Checkpoint Therapeutics, Inc. and Encourages Investors to Contact the Firm
-
HIRERIGHT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against HireRight Holdings Corporation and Encourages Investors to Contact the Firm
-
TORO ALERT: Bragar Eagel & Squire, P.C. is Investigating The Toro Company on Behalf of Toro Stockholders and Encourages Investors to Contact the Firm
-
VERADIGM ALERT: Bragar Eagel & Squire, P.C. is Investigating Veradigm Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
-
BIIB Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Biogen Inc. Class Action
-
CMBM Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Cambium Networks Corporation Class Action
-
DRCT Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Direct Digital Holdings, Inc. Class Action